analiza aiqbench
This scoping review evaluates how AI and machine learning interventions across the medication lifecycle can significantly reduce errors in resource-constrained rural healthcare settings. While demonstrating substantial potential for improving patient safety through automated monitoring, the analysis highlights critical implementation barriers such as infrastructure gaps, financial constraints, and clinician resistance that must be addressed to scale these solutions effectively.
Improving Rural Medication Safety with AI: A Scoping Review
arXiv:2608.18135v1 Announce Type: new Abstract: Introduction: Medication errors (MEs) represent a significant threat to global healthcare systems, contributing to patient harm. Introducing artificial intelligence (AI) in rural healthcare enhances patient safety. The aim is to explore the applications and effectiveness of AI technologies in enhancing patient safety and reducing medication errors in rural health settings. Methods: A scoping review was conducted through a systematic literature search spanning 2012 to 2025 across multiple databases, including EBSCohost, Emcare (Ovid), MEDLINE, and the ProQuest Consumer Health Database. Twelve primary studies from nine different nations were examined. Data were analysed thematically to obtain insights on AI interventions across the medication process. Results: AI technologies have been integrated into every stage of medication management, right from prescribing and dispensing to administration and post-administration monitoring. Four key themes came to light: (1) the various types of AI being utilised (like Clinical Decision Support Systems, Machine Learning, Natural Language Processing, and smart pumps); (2) the phases of the medication process that are affected; (3) how effective these technologies are in minimising errors and boosting workflow safety; and (4) rural-specific challenges including infrastructure, staff training, system integration, and alert fatigue. Several studies have demonstrated that machine learning-based surveillance improves incident detection and reduces prescribing and transcription errors by an impressive 34% to 80%. Barriers included lack of governance frameworks, financial limitations, and clinician resistance, which still present major obstacles. Conclusion: In rural healthcare, AI technologies hold great potential for enhancing pharmaceutical safety. They can allow data-driven monitoring, automate processes, and offer clinical decision assistance.
Abstract:Introduction: Medication errors (MEs) represent a significant threat to global healthcare systems, contributing to patient harm. Introducing artificial intelligence (AI) in rural healthcare enhances patient safety. The aim is to explore the applications and effectiveness of AI technologies in enhancing patient safety and reducing medication errors in rural health settings. Methods: A scoping review was conducted through a systematic literature search spanning 2012 to 2025 across multiple databases, including EBSCohost, Emcare (Ovid), MEDLINE, and the ProQuest Consumer Health Database. Twelve primary studies from nine different nations were examined. Data were analysed thematically to obtain insights on AI interventions across the medication process. Results: AI technologies have been integrated into every stage of medication management, right from prescribing and dispensing to administration and post-administration monitoring. Four key themes came to light: (1) the various types of AI being utilised (like Clinical Decision Support Systems, Machine Learning, Natural Language Processing, and smart pumps); (2) the phases of the medication process that are affected; (3) how effective these technologies are in minimising errors and boosting workflow safety; and (4) rural-specific challenges including infrastructure, staff training, system integration, and alert fatigue. Several studies have demonstrated that machine learning-based surveillance improves incident detection and reduces prescribing and transcription errors by an impressive 34% to 80%. Barriers included lack of governance frameworks, financial limitations, and clinician resistance, which still present major obstacles. Conclusion: In rural healthcare, AI technologies hold great potential for enhancing pharmaceutical safety. They can allow data-driven monitoring, automate processes, and offer clinical decision assistance.
Artificial Intelligence (cs.AI)
arXiv:2608.18135 [cs.AI]
(or arXiv:2608.18135v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2608.18135 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Text integral sub licența deschisă a publicației · 345 cuvinte
Subiecte conexe

Digital States 2026: AI Moves From Experiment to Infrastructure
govtech.com · 24 sept. 2026

Concrete Evaluations to Investigate the OpenAI Model That Hacked Hugging Face
AI Alignment Forum · 3 aug. 2026
A Red Line and Oversight Framework for Government AI Contracts
AI Alignment Forum · 18 iul. 2026

AI in healthcare: applications and best practices
Databricks · 24 iul. 2026